You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Avoiding The Pitfalls Of Sponsored Multicentre Research In General Practice
Heather A. Waldron and Ronald F. Cookson
BMJ: British Medical Journal
Vol. 307, No. 6915 (Nov. 20, 1993), pp. 1331-1334
Published by: BMJ
Stable URL: http://www.jstor.org/stable/29721778
Page Count: 4
You can always find the topics here!Topics: General practice, Experimentation, Clinical trials, Clinical research, Diplomatic protocol, Ethics committees, Pharmaceutical industry, Medical research, Pharmaceutical preparations, Business structures
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Research in general practice is becoming increasingly popular, and most general practitioners will sooner or later have to decide whether to become involved with clinical trials sponsored by drug companies. This paper outlines the advantages and disadvantages of multicentre research—based on experience of running a research group since the early 1980s—to enable doctors to reach the appropriate decision and to avoid involvement in trials which are either unethical or ineffective.
BMJ: British Medical Journal © 1993 BMJ